Korean J Dermatol.
2022 Feb;60(2):135-138.
A Case of Nummular Eczema-Like Eruption after Secukinumab Treatment
- Affiliations
-
- 1Department of Dermatology, Chungbuk National University College of Medicine, Cheongju, Korea
Abstract
- Secukinumab is an anti-interleukin 17A monoclonal antibody used for treating chronic plaque psoriasis. Eczematous eruption is a relatively unknown adverse effect of secukinumab. A 32-year-old man developed eczematous eruptions on both lower extremities following secukinumab treatment for severe plaque psoriasis. The lesions were clinically diagnosed as a nummular eczema-like eruption and were treated with topical corticosteroids without switching or stopping secukinumab. Considering the increased use of secukinumab and other interleukin-17A inhibitors, dermatologists should be aware of the cutaneous side effects of the drug.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Eczema Herpeticum in Darier's Disease
- Patch Testing in Nummular Eczema: Comparison of Patch Test Resultsbetween Nummular Eczema and Atopic Dermatitis
- Eczematous Vesicular Rruption and Exacerbation of Chronic Spontaneous Urticaria Associated with Secukinumab
- A Case of Eczema Herpeticum
- Clinical Study on Nummula Eczema
